Table 1.
Summary parameters for alternative PRSs.a
No of SNPs | Mean controls | Mean cases | SD controls | SD cases | LogOR per 1 SD | 95%CI | α GLM b | 95%CI | α RL c | 95%CI | Ratio (αRL:LogOR per 1 SD) | Predicted αRL | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BCAC PRS313 | 313 | −0.424 | −0.114 | 0.611 | 0.619 | 0.497 | 0.476 – 0.519 | 0.397 | 0.378 – 0.415 | 0.501 | 0.485 – 0.517 | 1.006 | 0.501 |
BRIDGES | 306 | −0.422 | −0.114 | 0.608 | 0.615 | 0.495 | 0.474 – 0.517 | 0.394 | 0.376 – 0.413 | 0.498 | 0.481 – 0.512 | 1.005 | 0.499 |
PERSPECTIVE | 295 | −0.448 | −0.147 | 0.599 | 0.609 | 0.489 | 0.468 – 0.511 | 0.389 | 0.371 – 0.408 | 0.492 | 0.476 – 0.507 | 1.005 | 0.492 |
EASTGLH | 303 | −0.407 | −0.100 | 0.606 | 0.613 | 0.494 | 0.472 – 0.516 | 0.394 | 0.375 – 0.412 | 0.497 | 0.481 – 0.513 | 1.005 | 0.497 |
PRISMA | 268 | 0.322 | 0.575 | 0.558 | 0.565 | 0.446 | 0.424 – 0.467 | 0.358 | 0.339 – 0.376 | 0.451 | 0.436 – 0.468 | 1.013 | 0.448 |
eMERGE | 308 | −0.456 | −0.150 | 0.608 | 0.616 | 0.495 | 0.473 – 0.516 | 0.394 | 0.376 – 0.413 | 0.498 | 0.483 – 0.513 | 1.007 | 0.498 |
DBDS299 | 299 | −0.508 | −0.211 | 0.596 | 0.605 | 0.486 | 0.465 – 0.508 | 0.387 | 0.369 – 0.406 | 0.490 | 0.474 – 0.507 | 1.007 | 0.489 |
BCAC PRS77 | 77 | −0.892 | −0.703 | 0.449 | 0.460 | 0.394 | 0.373 – 0.415 | 0.310 | 0.292 – 0.328 | 0.396 | 0.381 – 0.412 | 1.005 | 0.397 |
BCAC PRS3820 | 3820 | −0.445 | −0.199 | 0.460 | 0.463 | 0.518 | 0.496 – 0.540 | 0.412 | 0.393 – 0.431 | 0.516 | 0.501 – 0.533 | 0.996 | 0.521 |
WISDOM75 | 74 | −1.057 | −0.835 | 0.567 | 0.573 | 0.360 | 0.338 – 0.381 | 0.281 | 0.263 – 0.299 | 0.360 | 0.344 – 0.373 | 1.000 | 0.362 |
WISDOM128 | 126 | −0.180 | 0.040 | 0.464 | 0.478 | 0.449 | 0.427 – 0.470 | 0.355 | 0.337 – 0.374 | 0.452 | 0.437 – 0.470 | 1.007 | 0.452 |
PRS constructed as above but excluding SNPs correlated with CHEK2*1100delC | |||||||||||||
BCAC PRS311 | 311 | −0.092 | 0.217 | 0.609 | 0.618 | 0.496 | 0.474 – 0.518 | 0.395 | 0.377 – 0.414 | 0.498 | 0.483 – 0.512 | 1.005 | 0.499 |
BRIDGES | 305 | −0.428 | −0.121 | 0.607 | 0.615 | 0.495 | 0.473 – 0.516 | 0.394 | 0.375 – 0.412 | 0.497 | 0.481 – 0.511 | 1.005 | 0.498 |
PERSPECTIVE | 293 | −0.116 | 0.183 | 0.598 | 0.607 | 0.488 | 0.466 – 0.510 | 0.388 | 0.369 – 0.406 | 0.490 | 0.474 – 0.505 | 1.004 | 0.491 |
EASTGLH | 301 | −0.075 | 0.230 | 0.604 | 0.612 | 0.492 | 0.471 – 0.514 | 0.392 | 0.374 – 0.411 | 0.495 | 0.479 – 0.510 | 1.004 | 0.496 |
eMERGE | 306 | −0.124 | 0.181 | 0.606 | 0.614 | 0.493 | 0.471 – 0.515 | 0.393 | 0.374 – 0.411 | 0.496 | 0.481 – 0.511 | 1.006 | 0.496 |
DBDS297 | 297 | −0.177 | 0.119 | 0.594 | 0.603 | 0.485 | 0.463 – 0.506 | 0.386 | 0.367 – 0.404 | 0.487 | 0.472 – 0.502 | 1.006 | 0.488 |
BCAC PRS3818 | 3818 | −0.227 | 0.017 | 0.459 | 0.462 | 0.517 | 0.495 – 0.539 | 0.411 | 0.392 – 0.430 | 0.514 | 0.501 – 0.535 | 0.995 | 0.520 |
SNP, single nucleotide polymorphism; SD, standard deviation, OR; Odds Ratio; CI, Confidence Interval; GLM, Generalized Linear Model; RL, Retrospective Likelihood.
Results based on 22767 controls and 16151 cases in the prospective and validation sets from Mavaddat et al. (3). European women with known age and age less than 80;
α GLM is based on logistic regression adjusted for country in which studies were conducted and 10 principal components.
α RL is based on retrospective likelihood method as described in Materials and Methods and Supplementary Methods.
BRIDGES includes 22_29203724_C_T but not 22_29551872_A_G.
BCAC PRS313, BCAC 3820, eMERGE, DBDS299, EASTGLH and PERSPECTIVE include both 22_29203724_C_T and 22_29551872_A_G.
PRISMA has neither 22_29551872_A_G nor 22_29203724_C_T and includes 37 surrogates.